We are live on
!
Find out more
BC
Bridgefront Capital Portfolio holdings
AUM
$402M
1-Year Est. Return
18.17%
This Fund
S&P 500
This Quarter
Est. Return
+4.66%
1 Year Est. Return
+18.17%
3 Year Est. Return
+38.15%
5 Year Est. Return
+29.06%
10 Year Est. Return
–
AUM
$265M
AUM Growth
-$55.9M
(-17%)
Cap. Flow
-$59M
Cap. Flow
% of AUM
-22.25%
Top 10 Holdings %
Top 10 Hldgs %
6.41%
Holding
1,024
New
385
Increased
78
Reduced
113
Closed
447
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$1.93M |
| 2 |
Corpay
CPAY
|
+$1.79M |
| 3 |
FISV
Fiserv Inc
FISV
|
+$1.72M |
| 4 |
JetBlue
JBLU
|
+$1.66M |
| 5 |
eBay
EBAY
|
+$1.65M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$2.59M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.29M |
| 3 |
Estee Lauder
EL
|
+$2.19M |
| 4 |
Zoetis
ZTS
|
+$2.14M |
| 5 |
Roper Technologies
ROP
|
+$1.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.99% |
| 2 | Technology | 14.15% |
| 3 | Healthcare | 13.19% |
| 4 | Financials | 13.02% |
| 5 | Industrials | 11.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
AptarGroup
ATR
$8.45B
| – | – |
-3,028
| Closed | -$429K |
|
602
Atara Biotherapeutics
ATRA
$71.2M
| – | – |
-492
| Closed | -$177K |
|
|
OPTU
603
Optimum Communications Inc
OPTU
$316M
| – | – |
-15,263
| Closed | -$497K |
|
604
Avanos Medical
AVNS
$1.17B
| – | – |
-6,770
| Closed | -$296K |
|
605
Axsome Therapeutics
AXSM
$12.4B
| – | – |
-9,257
| Closed | -$524K |
|
606
Boeing
BA
$165B
| – | – |
-3,049
| Closed | -$777K |
|
607
Alibaba
BABA
$269B
| – | – |
-1,147
| Closed | -$260K |
|
|
BAND
608
Bandwidth Inc
BAND
$1.91B
| – | – |
-1,809
| Closed | -$229K |
|
609
Credicorp
BAP
$30.9B
| – | – |
-8,080
| Closed | -$1.1M |
|
610
Banco Bradesco
BBD
$38.1B
| – | – |
-58,168
| Closed | -$226K |
|
611
BCE
BCE
$19.9B
| – | – |
-17,353
| Closed | -$783K |
|
612
Brink's
BCO
$5.02B
| – | – |
-5,597
| Closed | -$443K |
|
613
BioCryst Pharmaceuticals
BCRX
$2.37B
| – | – |
-20,028
| Closed | -$204K |
|
614
Becton Dickinson
BDX
$43.1B
| – | – |
-2,159
| Closed | -$512K |
|
615
Bunge Global
BG
$23.6B
| – | – |
-10,849
| Closed | -$860K |
|
616
BGC Group
BGC
$5.58B
| – | – |
-42,390
| Closed | -$205K |
|
617
BHP
BHP
$213B
| – | – |
-6,890
| Closed | -$426K |
|
618
Bilibili
BILI
$7.18B
| – | – |
-6,817
| Closed | -$730K |
|
619
Buckle
BKE
$2.19B
| – | – |
-8,545
| Closed | -$336K |
|
620
Brady Corp
BRC
$4.45B
| – | – |
-4,185
| Closed | -$224K |
|
|
BRFS
621
DELISTED
BRF SA
BRFS
| – | – |
-27,211
| Closed | -$122K |
|
622
Bruker
BRKR
$9.2B
| – | – |
-8,121
| Closed | -$522K |
|
623
AB InBev
BUD
$158B
| – | – |
-3,981
| Closed | -$250K |
|
624
Burlington
BURL
$22B
| – | – |
-1,884
| Closed | -$563K |
|
625
Beyond Meat
BYND
$288M
| – | – |
-2,820
| Closed | -$367K |
|
Similar funds
SCP
MM
P8IP
BWA
MI
TGV
SFCL
AIM
Bridgefront Capital's Q2 2021 Portfolio in Review
As of Q2 2021, Bridgefront Capital held 1,024 positions worth $265M, down 17% from $321M the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.
Bridgefront Capital withdrew a net $59M in Q2 2021, closing 447 positions and reducing 113 holdings. Its most notable exit was Alphabet (Google) Class C, an estimated $2.29M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 10% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Bridgefront Capital opened a new position in Comcast worth $1.96M.
- Bridgefront Capital's largest Q2 2021 buy was Comcast: 34,448 shares worth $1.96M.
- Bridgefront Capital added most to Stryker in Q2 2021, an estimated $1.61M increase.
- Bridgefront Capital's biggest Q2 2021 reduction was Medtronic, cutting an estimated $2.59M.
- Bridgefront Capital fully exited Alphabet (Google) Class C in Q2 2021, selling an estimated $2.29M.
- Bridgefront Capital's ten largest holdings make up 6.4% of its $265M portfolio in Q2 2021.
- Bridgefront Capital opened 385 new positions and closed 447 in Q2 2021.
- Bridgefront Capital's portfolio value fell 17% quarter-over-quarter to $265M.
Based on Bridgefront Capital's 13F filing for Q2 2021, filed 12 Aug 2021.